• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

michelle.giles@unimelb.edu.au

Credentials


Position
Clinician Scientist Vaccine Research Leader
Department of Infectious Diseases
ORCID

0000-0003-3007-1822

Prof Michelle Giles

Clinician Scientist Vaccine Research Leader
Department of Infectious Diseases

202 Scholarly works
10 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Coverage and missed opportunities for routine vaccination in adult travellers: a single-centre observational study
    DOI: 10.1016/j.vaccine.2026.128735
  • 2026

    Journal article

    ATAGI Targeted Review 2024: Immunisation strategies for prevention and control of respiratory syncytial virus disease in Australia
    DOI: 10.33321/cdi.2026.50.034
  • 2026

    Journal article

    ATAGI 2024 Annual Statement on Immunisation
    DOI: 10.33321/cdi.2026.50.032
  • 2025

    Research grants (ARC, NHMRC, MRFF)

    Promoat: An Adaptive Platform Trial of Antibiotic Therapy to Improve Outcomes From Preterm Prelabour Rupture of Membranes
  • 2024

    Research grants (ARC, NHMRC, MRFF)

    PLATIPUS: A Platform for Adaptive Trials in Perinatal Units
  • 2024

    Research contracts (non-grants)

    A Phase 3, Multicenter, Observer-Blind, Randomized, Controlled Study to Evaluate the Immunogenicity, Reactogenicity, and Safety of a Self-Amplifying RNA COVID-19 Vaccine (ARCT-2303), Administered Concomitantly With Quadrivalent Influenza Vaccines, in Adul
  • 2020

    Journal article

    COVID-19 and pregnancy: A review of clinical characteristics, obstetric outcomes and vertical transmission
    DOI: 10.1111/ajo.13204
Michelle Giles

RECENT SCHOLARLY WORKS

  • 2026

    Journal article

    ATAGI 2025 Annual Statement on Immunisation
    DOI: 10.33321/cdi.2026.50.033
  • 2026

    Journal article

    The Maternal Vaccine Study Protocol: A Victorian Cohort Study Evaluating Infant and Childhood Safety and Health and Developmental Outcomes After Vaccination Against Respiratory Viruses in Pregnancy
    DOI: 10.3390/vaccines14050449
  • 2026

    Journal article

    Immunisation against vaccine-preventable diseases in individuals receiving immunosuppressive targeted therapies
    DOI: 10.1016/j.vaccine.2026.128399
  • 2026

    Journal article

    Cytomegalovirus in pregnancy: prevention, maternal screening, and the role of antivirals.
    DOI: 10.18773/austprescr.2026.011
  • 2026

    Journal article

    Preventing infections in immunosuppressed patients
    DOI: 10.18773/austprescr.2026.003
  • 2026

    Journal article

    Drivers, barriers, and implications of mpox vaccine uptake in Australia among gay, bisexual, and other men who have sex with men: results from a prospective observational mixed-methods study (2022–2024)
    DOI: 10.1016/j.vaccine.2025.128041
  • 2026

    Journal article

    The MyVax Study: Understanding pregnant women’s priorities for maternal vaccination
    DOI: 10.1016/j.anzjph.2026.100552

RECENT PROJECTS

  • 2025

    Research contracts (non-grants)

    POPSICLE Study Analysis

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224